![]() |
|
|
D Demolle, M Lecomte, O Boutherin-Falson, EJ Cragoe , AC Nairn and JM Boeynaems
Institute of Interdisciplinary Research, School of Medicine, Universite Libre de Bruxelles, Belgium.
5-(N-Ethyl-N-isopropyl)amiloride (EIPA), a potent inhibitor of Na+/H+ antiport, reduced [35S]methionine incorporation in proteins and induced the phosphorylation of a Mr 95,000 protein in bovine aortic endothelial cells. This protein was previously shown to become phosphorylated in response to ATP, bradykinin, and A23187 (1) and was identified as elongation factor-2 (2). The action of EIPA was independent of changes in cytosolic pH, because it was neither mimicked by sodium acetate nor inhibited by ammonium chloride, and it was reproduced by 2',4'- dimethylbenzamil, an analog of amiloride that is inactive on the Na+/H+ antiport. Furthermore, EIPA enhanced the Ca2(+)-dependent phosphorylation of a similar Mr 95,000 protein in a cell-free system, rabbit reticulocyte lysate, where an inhibitory effect of amiloride on protein synthesis has already been described (3). Because phosphorylation decreases the activity of elongation factor-2, our observation might explain why amiloride analogs inhibit protein synthesis.
This article has been cited by other articles:
![]() |
F. U. Müller, P. Bokník, J. Knapp, J. Neumann, U. Vahlensieck, E. Oetjen, H. H. Scheld, and W. Schmitz Identification and expression of a novel isoform of cAMP response element modulator in the human heart FASEB J, September 1, 1998; 12(12): 1191 - 1199. [Abstract] [Full Text] |
||||
![]() |
N. T. Redpath, N. T. Price, and C. G. Proud Cloning and Expression of cDNA Encoding Protein Synthesis Elongation Factor-2 Kinase J. Biol. Chem., July 19, 1996; 271(29): 17547 - 17554. [Abstract] [Full Text] [PDF] |
||||